-
Arachidonic Acid for Reproducible Cell Assays
2026-09-09
Learn how Arachidonic Acid (SKU C4223) can help researchers design more interpretable viability, proliferation, and inflammation assays. This scenario-based guide covers lipid signaling, solvent compatibility, concentration planning, data interpretation, and practical product selection.
-
Ceftolozane/Tazobactam: Evidence and Clinical Relevance
2026-09-09
The reference review examines ceftolozane/tazobactam as an antipseudomonal cephalosporin/β-lactamase inhibitor combination designed to address resistant gram-negative infections. Its principal contribution is an integrated analysis of antibacterial mechanisms, pharmacokinetics, pharmacodynamics, resistance, clinical trial evidence, dosing, and safety for complicated intraabdominal and urinary tract infections.
-
GlycoRNA–RBP Nanodomains and TAT Entry
2026-09-08
The reference preprint presents evidence that cell-surface RNA-binding proteins and glycoRNAs organize into extracellular nanoclusters that support entry of the cell-penetrating peptide TAT. Its perturbation-based design links surface RNA, cluster integrity, and peptide internalization, expanding conventional models of plasma-membrane organization while leaving the molecular anchoring mechanism open.
-
Haloprogin: Evidence from a 1970 Topical Antifungal Study
2026-09-08
The 1970 reference study established Haloprogin as a topical antifungal with dermatophyte activity comparable to tolnaftate, while identifying additional activity against Candida species and selected Gram-positive bacteria. Its combination of serial-dilution testing, fungicidal confirmation, and guinea pig infection models provides a useful evidence framework for contemporary dermatophytosis and topical antimicrobial research.
-
Camostat Mesilate: ENaC and Fibrosis Research
2026-09-07
Camostat Mesilate is a trypsin-like protease inhibitor used to study airway epithelial sodium channel regulation, plasmin activity, TGF-β signaling, and hepatic fibrosis. Product information reports an ENaC-related IC50 of 50 nM, while animal-model data support further investigation of plasmin inhibition and reduced hepatic stellate cell activation.
-
Baicalin Methyl Ester for Intestinal Barrier Research
2026-09-05
Baicalin methyl ester offers a focused workflow for studying inflammatory signaling and tight-junction recovery after epithelial barrier injury. Its defined concentration range, pathway-linked readouts, and formulation constraints make it useful for connecting MODE-K cell assays with mouse intestinal inflammation models.
-
Cinoxacin Workflow Guide for Gram-Negative Studies
2026-09-05
Build more reproducible susceptibility, kill-kinetic, and resistance experiments with Cinoxacin, a DNA synthesis-targeting quinolone antibiotic. This guide connects practical assay design with urinary tract infection research, bacterial prostatitis research, and structured troubleshooting for gram-negative aerobic bacteria.
-
Sodium dicloxacillin monohydrate: Assay Guide
2026-09-04
Sodium dicloxacillin monohydrate is a focused tool for MSSA and Gram-positive bacterial infection research. This guide connects β-lactam pharmacology with analytical assay selection, explaining how to interpret potency, compartment effects, formulation chemistry, and translational limitations.
-
Gepotidacin Versus Nitrofurantoin in UTI Trials
2026-09-04
The EAGLE-2 and EAGLE-3 phase 3 trials evaluated oral gepotidacin, also known as GSK2140944, against nitrofurantoin for uncomplicated urinary tract infection. Gepotidacin met the prespecified non-inferiority criterion in both studies and was superior to nitrofurantoin in EAGLE-3, supporting clinical development of an oral antibiotic with a distinct bacterial topoisomerase pathway target.
-
Gepotidacin: Practical Antibacterial Workflows
2026-09-03
Gepotidacin, also known as GSK2140944, gives antibacterial research teams a mechanistically distinct way to investigate bacterial DNA replication inhibition and resistant pathogens. This workflow-focused guide covers assay setup, concentration design, translational interpretation, and troubleshooting for reproducible studies.
-
Nadolol (SQ-11725) Assay Workflows
2026-09-03
Nadolol (SQ-11725) provides a practical non-selective beta-receptor blockade tool for cardiovascular signaling, transporter, and pharmacokinetic assays. This workflow-focused guide shows how to separate receptor effects from exposure variability and adapt disease-state PK lessons from recent MASH research without overextending the evidence.
-
Prednisone: Mechanism, Evidence, and Workflows
2026-09-02
Prednisone is a synthetic corticosteroid used in research on lymphocyte suppression, apoptosis, neurodegeneration, and corticosteroid pharmacology. Its reported profile combines G1-phase arrest, IL-2 pathway suppression, dose- and time-dependent apoptosis, and defined DMSO handling requirements.
-
Bacitracin (B1670) Workflow and QC Guide
2026-09-02
Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. This guide covers solvent selection, storage, assay controls, and troubleshooting, but the product is not intended for diagnostic, clinical, or medical use.
-
L-NAME Hydrochloride: NOS Inhibition Guide
2026-09-01
L-NAME Hydrochloride, also called NG-nitro-L-arginine methyl ester hydrochloride, is a competitive nitric oxide synthase inhibitor for mechanistic research. The compound supports vascular tone regulation studies, hypertension research, and controlled analysis of nitric oxide and inflammatory signaling.
-
Stattic Workflow for STAT3 Inhibition Research
2026-08-31
Stattic provides a practical way to test whether STAT3 dimerization, phosphorylation, and nuclear signaling drive a phenotype. This workflow connects HNSCC radiosensitization with a carefully bounded lymphatic endothelial-cell application inspired by recent pathway research.